Isolagen to Initiate Clinical Trials for Additional Applications

Isolagen has announced plans for the commencement of clinical studies for additional applications of its proprietary Isolagen Process.

The company has identified lead investigators to initiate clinical trials for the application of the Isolagen Process in vocal cord repair and the treatment of the signs of aging in the hand by third quarter 2005.

In addition, the company anticipates the commencement of two dental studies in the fourth quarter of this year. Finally, the company expects to commence a Phase III trial for acne scarring as well in first quarter next year.